TALENT Biotechs

Medical Cannabis Drugs

Health Tech & Life Sciences
Acquired (Inactive) by Kalytera Therapeutics on Feb 2017 - closed due to acquisition

Company Overview

Snapshot

Founded in January 2014 by Moshe Yeshurun, TALENT Biotechs operates with 1–10 employees. The company was acquired by Kalytera Therapeutics in February 2017, marking a significant exit in the medical cannabis sector.

Business overview

TALENT Biotechs specializes in developing cannabidiol-based therapies, focusing on screening and leveraging patented pharmaceutical and medical technologies. The company accelerates the development process from research and clinical trials through Phase II into a Phase III starting point. Its primary focus has been on the use of cannabidiol for the prevention and treatment of graft-versus-host disease, a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation. Operating within the Health Tech & Life Sciences sector, specifically Pharma & Medical Biotechnology and Medical Cannabis, TALENT Biotechs serves the pharmaceutical industry.

Strategic signal

In February 2017, TALENT Biotechs was acquired by Kalytera Therapeutics for over $10 million. This acquisition highlights the increasing interest and investment in the medical cannabis sector, particularly for therapeutic applications. For investors, this signals a validation of TALENT Biotechs' cannabidiol-based drug development pipeline and the potential for significant returns in this emerging market.

Company Intelligence Q&A

What is TALENT Biotechs' primary focus?
TALENT Biotechs develops cannabidiol-based therapies, with a specific focus on preventing and treating graft-versus-host disease, a complication of allogeneic hematopoietic stem cell transplantation.
When was TALENT Biotechs acquired?
TALENT Biotechs was acquired by Kalytera Therapeutics in February 2017.
What was the reported value of the acquisition?
In February 2017, Kalytera Therapeutics acquired TALENT Biotechs for over $10 million.
Who founded TALENT Biotechs?
TALENT Biotechs was founded by Moshe Yeshurun in January 2014.
What is the status of TALENT Biotechs' product development?
TALENT Biotechs' product development is in the Clinical Trial stage, specifically leveraging research and clinical trials through Phase II into a Phase III starting point.

External links